CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $25M | +114.1% | 17.6% | 46.0% |
| Capital expenditures (TTM) | $25M |
|---|---|
| YoY | +114.1% |
| 5-year CAGR | 17.6% |
| 10-year CAGR | 46.0% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $25M | +535.1% |
| 2024 | $3.9M | +175.8% |
| 2023 | $1.4M | −87.5% |
| 2022 | $11M | −76.8% |
| 2021 | $49M | +342.2% |
| 2020 | $11M | +322.0% |
| 2019 | $2.6M | +194.6% |
| 2018 | $889K | −69.1% |
| 2017 | $2.9M | +80.3% |
| 2016 | $1.6M | +184.0% |
| 2015 | $562K | −49.1% |
| 2014 | $1.1M | +103.7% |
| 2013 | $542K | +333.6% |
| 2012 | $125K | −71.8% |
| 2011 | $443K | −10.1% |
| 2010 | $493K | −10.4% |
| 2009 | $550K | — |